Literature DB >> 16099864

Estrogens up-regulate the Fas/FasL apoptotic pathway in lactotropes.

G Jaita1, M Candolfi, V Zaldivar, S Zárate, L Ferrari, D Pisera, M G Castro, A Seilicovich.   

Abstract

The Fas/FasL system provides the major apoptotic mechanism for many cell types, participating in cell turnover in hormone-dependent tissues. In the present study, we localized both Fas and FasL in anterior pituitary cells, mainly in lactotropes and somatotropes. The percentage of anterior pituitary cells showing immunoreactivity for Fas or FasL was higher in cells from rats killed in proestrus than in diestrus. Also, the proportion of pituitary cells from ovariectomized (OVX) rats expressing Fas or FasL increased in the presence of 17beta-estradiol (10(-9) M). This steroid increased the percentage of lactotropes with immunoreactivity for Fas or FasL and the percentage of somatotropes expressing Fas. Activation of Fas by an agonist anti-Fas antibody (Mab-Fas) decreased the vi-ability-3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT assay)-of anterior pituitary cells from OVX rats cultured in the presence of 17beta-estradiol. Also, membrane-bound FasL decreased cell viability-[3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium] assay (MTS assay)-only when anterior pituitary cells from OVX rats were incubated with 17beta-estradiol. Moreover, FasL increased the percentage of hypodiploid anterior pituitary cells (flow cytometry). Mab-Fas increased the percentage of terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end-labeling (TUNEL)-positive pituitary cells and lactotropes from OVX rats only when cells were incubated in the presence of 17beta-estradiol. Also, Mab-Fas triggered apoptosis of anterior pituitary cells from rats killed at proestrus but not at diestrus. Our results show that 17beta-estradiol up-regulates the expression of the Fas/FasL system in anterior pituitary cells and increases Fas-induced apoptosis in lactotropes, suggesting that Fas-induced apoptosis could be involved in the pituitary cell renewal during the estrous cycle.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16099864      PMCID: PMC1266288          DOI: 10.1210/en.2005-0279

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  41 in total

1.  Immunohistochemical analysis of Fas ligand expression in normal human tissues.

Authors:  S H Lee; M S Shin; W S Park; S Y Kim; S M Dong; H K Lee; J Y Park; R R Oh; J J Jang; J Y Lee; N J Yoo
Journal:  APMIS       Date:  1999-11       Impact factor: 3.205

2.  Characterization of signaling pathways leading to Fas expression induced by TNF-alpha: pivotal role of NF-kappaB.

Authors:  Donatella Starace; Anna Riccioli; Alessio D'Alessio; Claudia Giampietri; Simonetta Petrungaro; Roberta Galli; Antonio Filippini; Elio Ziparo; Paola De Cesaris
Journal:  FASEB J       Date:  2004-12-15       Impact factor: 5.191

3.  Caspase 8 expression and signaling in Fas injury-resistant human fetal astrocytes.

Authors:  K Wosik; B Becher; A Ezman; J Nalbantoglu; J P Antel
Journal:  Glia       Date:  2001-03-01       Impact factor: 7.452

4.  Testicular FasL is expressed by sperm cells.

Authors:  A D'Alessio; A Riccioli; P Lauretti; F Padula; B Muciaccia; P De Cesaris; A Filippini; S Nagata; E Ziparo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-27       Impact factor: 11.205

5.  Proestrous surge of gonadotropin-releasing hormone secretion inhibits apoptosis of anterior pituitary cells in cycling female rats.

Authors:  Ping Yin; Jun Arita
Journal:  Neuroendocrinology       Date:  2002-11       Impact factor: 4.914

6.  Progesterone antagonizes the permissive action of estradiol on tumor necrosis factor-alpha-induced apoptosis of anterior pituitary cells.

Authors:  M Candolfi; G Jaita; V Zaldivar; S Zárate; L Ferrari; D Pisera; M G Castro; A Seilicovich
Journal:  Endocrinology       Date:  2004-11-04       Impact factor: 4.736

7.  Differential regulation and function of the Fas/Fas ligand system in human trophoblast cells.

Authors:  Sarit Aschkenazi; Shawn Straszewski; Karlijn M A Verwer; Harald Foellmer; Thomas Rutherford; Gil Mor
Journal:  Biol Reprod       Date:  2002-06       Impact factor: 4.285

8.  Estrogens sensitize anterior pituitary gland to apoptosis.

Authors:  D Pisera; M Candolfi; S Navarra; J Ferraris; V Zaldivar; G Jaita; M G Castro; A Seilicovich
Journal:  Am J Physiol Endocrinol Metab       Date:  2004-06-01       Impact factor: 4.310

9.  Cellular proliferation in the anterior pituitary gland of normal adult rats: influences of sex, estrous cycle, and circadian change.

Authors:  Y Oishi; M Okuda; H Takahashi; T Fujii; S Morii
Journal:  Anat Rec       Date:  1993-01

10.  Regulation of Fas ligand expression by estrogen in normal ovary.

Authors:  Eva Sapi; Wendi D Brown; Sarit Aschkenazi; Chung Lim; Amanda Munoz; Barry M Kacinski; Thomas Rutherford; Gil Mor
Journal:  J Soc Gynecol Investig       Date:  2002 Jul-Aug
View more
  10 in total

1.  Effect of prolonged use of high dose of tibolone on the vagina of ovariectomized rats.

Authors:  Helene Nara Henriques; Ana Carolina Bergmann de Carvalho; Porphirio José Soares Filho; José Augusto Soares Pantaleão; Maria Angélica Guzmán-Silva
Journal:  Int J Exp Pathol       Date:  2011-04-26       Impact factor: 1.925

2.  Gonadal steroids modulate Fas-induced apoptosis of lactotropes and somatotropes.

Authors:  Gabriela Jaita; Sandra Zárate; Luciana Ferrari; Daniela Radl; Jimena Ferraris; Guadalupe Eijo; Verónica Zaldivar; Daniel Pisera; Adriana Seilicovich
Journal:  Endocrine       Date:  2010-11-11       Impact factor: 3.633

3.  Promoter polymorphism of FASL confers protection against female-specific cancers and those of FAS impact the cancers divergently.

Authors:  Sateesh Reddy Nallapalle; Sarika Daripally; V T S Vidudala Prasad
Journal:  Tumour Biol       Date:  2014-12-04

4.  Dopamine-induced apoptosis of lactotropes is mediated by the short isoform of D2 receptor.

Authors:  Daniela Betiana Radl; Jimena Ferraris; Valeria Boti; Adriana Seilicovich; Dipak Kumar Sarkar; Daniel Pisera
Journal:  PLoS One       Date:  2011-03-25       Impact factor: 3.240

5.  N-terminal prolactin-derived fragments, vasoinhibins, are proapoptoptic and antiproliferative in the anterior pituitary.

Authors:  Jimena Ferraris; Daniela Betiana Radl; Sandra Zárate; Gabriela Jaita; Guadalupe Eijo; Verónica Zaldivar; Carmen Clapp; Adriana Seilicovich; Daniel Pisera
Journal:  PLoS One       Date:  2011-07-07       Impact factor: 3.240

6.  Antiapoptotic factor humanin is expressed in normal and tumoral pituitary cells and protects them from TNF-α-induced apoptosis.

Authors:  María Florencia Gottardo; Gabriela Jaita; María Laura Magri; Sandra Zárate; Mariela Moreno Ayala; Jimena Ferraris; Guadalupe Eijo; Daniel Pisera; Marianela Candolfi; Adriana Seilicovich
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

7.  Prolactin induces apoptosis of lactotropes in female rodents.

Authors:  Jimena Ferraris; Sandra Zárate; Gabriela Jaita; Florence Boutillon; Marie Bernadet; Julien Auffret; Adriana Seilicovich; Nadine Binart; Vincent Goffin; Daniel Pisera
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

8.  Programmed cell death 4 (PDCD4) suppresses metastastic potential of human hepatocellular carcinoma cells.

Authors:  Shuhong Zhang; Jianfeng Li; Ying Jiang; Yijun Xu; Chengyong Qin
Journal:  J Exp Clin Cancer Res       Date:  2009-05-29

9.  Fas receptor is required for estrogen deficiency-induced bone loss in mice.

Authors:  Natasa Kovacic; Danka Grcevic; Vedran Katavic; Ivan Kresimir Lukic; Vladimir Grubisic; Karlo Mihovilovic; Hrvoje Cvija; Peter Ian Croucher; Ana Marusic
Journal:  Lab Invest       Date:  2010-01-18       Impact factor: 5.662

10.  Prolonged oestrogen treatment does not correlate with a sustained increase in anterior pituitary mitotic index in ovariectomized Wistar rats.

Authors:  L A Nolan; A Levy
Journal:  J Endocrinol       Date:  2008-12-23       Impact factor: 4.286

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.